Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability & Proliferation Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes WST-8, a water-soluble tetrazolium salt, to quantitatively assess cell viability via mitochondrial dehydrogenase activity in viable cells (DOI). The assay produces a water-soluble formazan dye, facilitating rapid and direct quantification without organic solvents. CCK-8 displays higher sensitivity and safety compared to MTT and XTT-based methods (source). The method is widely used for cancer research, neurodegenerative disease studies, and cytotoxicity screening (APExBIO). Key advantages include homogeneous workflow, minimal hands-on time, and compatibility with high-throughput screening.

Biological Rationale

Cell viability and proliferation assays are fundamental in biomedical research, enabling quantification of live, metabolically active cells. Viability reflects mitochondrial dehydrogenase activity, a proxy for cellular metabolic health. Disease models such as cancer and neurodegenerative disorders require robust, sensitive, and reproducible cell counting methods (DOI). Traditional methods like MTT and XTT assays are limited by insoluble products or complex workflows. WST-8-based assays overcome these limitations by producing water-soluble products, allowing direct measurement in microplates. Consistent quantification of cell health is essential for evaluating cytotoxicity, proliferation, and drug efficacy.

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8 contains WST-8, a water-soluble tetrazolium salt. Live cells with active mitochondrial dehydrogenases reduce WST-8 to a water-soluble formazan dye. This reaction is directly proportional to the number of living cells. The assay is performed by adding WST-8 reagent directly to cells in culture, incubating at 37°C for 1–4 hours, then measuring absorbance at 450 nm using a microplate reader (APExBIO). The resulting absorbance correlates linearly with viable cell number within a defined range. Unlike MTT, there is no need for solubilization steps. The reaction is non-radioactive and non-toxic, supporting downstream applications.

Evidence & Benchmarks

• CCK-8 (WST-8) achieves a detection limit of ~100 cells/well under standard 96-well plate conditions (37°C, 5% CO₂, 2 h incubation) (DOI).
• Absorbance at 450 nm shows linearity (R² > 0.99) in the range of 100–10,000 cells/well (source).
• Compared to MTT, CCK-8 reduces hands-on time by 30–40% and eliminates toxic organic solvents (source).
• CCK-8 is compatible with proliferation, cytotoxicity, and metabolic activity assays in both adherent and suspension cells (source).
• The water-soluble formazan product simplifies workflow integration with automated, high-throughput screening platforms (DOI).

Applications, Limits & Misconceptions

CCK-8 is widely used for:

• Cancer research: Quantifying cell proliferation and chemotherapeutic cytotoxicity (see more; this article extends metabolic context by linking to PTM influences).
• Neurodegenerative disease models: Assessing neuronal viability under stress (see more; here, we clarify workflow integration and safety).
• Cytotoxicity screening: Evaluating drug-induced cell death across diverse cell types.
• Cellular metabolic activity assessment: Monitoring mitochondrial function via dehydrogenase activity.

Common Pitfalls or Misconceptions

• Does not measure apoptosis-specific mechanisms: CCK-8 detects overall viability, not the specific mode of cell death.
• Sensitive to high reducing agents: Extracellular reductants (e.g., ascorbate, DTT) can produce false positives.
• Not suitable for non-metabolically active cells: WST-8 reduction depends on mitochondrial activity; cells with low metabolic rates may yield underestimates.
• Does not distinguish between cell cycle phases: The assay is quantitative but not qualitative for cell state analysis.
• Interference by colored compounds: Media or test compounds absorbing at 450 nm may confound results.

Workflow Integration & Parameters

CCK-8 offers a homogeneous, one-step workflow. Recommended protocol: seed 100–10,000 cells/well in a 96-well plate, incubate overnight, add 10 µL CCK-8 reagent per 100 µL medium, incubate at 37°C for 1–4 hours, and read absorbance at 450 nm. No cell washing or solubilization is needed (the K1018 kit). The product is stable at room temperature and can be used with both adherent and suspension cells. For high-throughput screening, the water-soluble dye supports rapid, automated readout. The non-toxic nature allows further downstream analysis on the same cells. For comprehensive benchmarking and workflow guidance, see (ref), which this article updates by integrating latest PTM-related insights.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) from APExBIO provides a rapid, sensitive, and reproducible solution for cell viability and proliferation measurement in a wide range of research contexts. Its water-soluble WST-8 chemistry, safety profile, and workflow simplicity make it a preferred choice over traditional tetrazolium-based assays. While not suited for mechanistic apoptosis studies or cells with minimal mitochondrial activity, its robust performance in cancer, neurobiology, and cytotoxicity screening is well established. Future developments may extend CCK-8’s application to multiplexed assays and real-time monitoring in complex models, building on advances in PTM and metabolic pathway research (DOI).